Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Cancer research and Erlotinib, with related work in Allosteric regulation, Urine, KRAS. Notable publications include 'Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase', 'Invasive candidiasis in intensive care units in China: a multicentre prospective observational study', and 'A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer'.
The KRAS-G12D mutation induces metabolic vulnerability in B-cell acute lymphoblastic leukemia
Previous mode of delivery affects subsequent pregnancy outcomes: a Chinese birth register study
A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer
Dysregulated Urinary Arginine Metabolism in Older Adults With Amnestic Mild Cognitive Impairment
Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase
Invasive candidiasis in intensive care units in China: a multicentre prospective observational study